vs
Side-by-side financial comparison of ATI INC (ATI) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
ATI INC is the larger business by last-quarter revenue ($1.2B vs $622.0M, roughly 1.9× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 8.2%, a 26.2% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs 0.4%). Over the past eight quarters, ATI INC's revenue compounded faster (6.2% CAGR vs 4.6%).
ATI Technologies Inc. was a Canadian semiconductor technology corporation based in Markham, Ontario, that specialized in the development of graphics processing units and chipsets. Founded in 1985, the company listed publicly in 1993 and was acquired by AMD in 2006. As a major fabless semiconductor company, ATI conducted research and development in-house and outsourced the manufacturing and assembly of its products. With the decline and eventual bankruptcy of 3dfx in 2000, ATI and its chief ri...
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
ATI vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $622.0M |
| Net Profit | $96.6M | $214.2M |
| Gross Margin | 23.2% | — |
| Operating Margin | 14.5% | 62.4% |
| Net Margin | 8.2% | 34.4% |
| Revenue YoY | 0.4% | 4.8% |
| Net Profit YoY | -29.5% | 2.9% |
| EPS (diluted) | $0.70 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $622.0M | ||
| Q3 25 | $1.1B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.1B | $568.2M | ||
| Q4 24 | $1.2B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.0B | $568.0M |
| Q4 25 | $96.6M | $214.2M | ||
| Q3 25 | $110.0M | $288.2M | ||
| Q2 25 | $100.7M | $30.2M | ||
| Q1 25 | $97.0M | $238.3M | ||
| Q4 24 | $137.1M | $208.2M | ||
| Q3 24 | $82.7M | $544.0M | ||
| Q2 24 | $81.9M | $102.0M | ||
| Q1 24 | $66.1M | $4.8M |
| Q4 25 | 23.2% | — | ||
| Q3 25 | 22.7% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | 20.6% | — | ||
| Q4 24 | 21.2% | — | ||
| Q3 24 | 21.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 18.9% | — |
| Q4 25 | 14.5% | 62.4% | ||
| Q3 25 | 14.4% | 70.1% | ||
| Q2 25 | 14.1% | 36.3% | ||
| Q1 25 | 12.8% | 94.0% | ||
| Q4 24 | 17.8% | 60.9% | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 13.0% | 50.2% | ||
| Q1 24 | 11.0% | -13.0% |
| Q4 25 | 8.2% | 34.4% | ||
| Q3 25 | 9.8% | 47.3% | ||
| Q2 25 | 8.8% | 5.2% | ||
| Q1 25 | 8.5% | 41.9% | ||
| Q4 24 | 11.7% | 35.1% | ||
| Q3 24 | 7.9% | 96.3% | ||
| Q2 24 | 7.5% | 19.0% | ||
| Q1 24 | 6.3% | 0.8% |
| Q4 25 | $0.70 | $0.49 | ||
| Q3 25 | $0.78 | $0.67 | ||
| Q2 25 | $0.70 | $0.07 | ||
| Q1 25 | $0.67 | $0.55 | ||
| Q4 24 | $0.94 | $0.46 | ||
| Q3 24 | $0.57 | $1.21 | ||
| Q2 24 | $0.58 | $0.23 | ||
| Q1 24 | $0.46 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $416.7M | $618.7M |
| Total DebtLower is stronger | $1.7B | $9.0B |
| Stockholders' EquityBook value | $1.8B | $9.7B |
| Total Assets | $5.1B | $19.6B |
| Debt / EquityLower = less leverage | 0.95× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $416.7M | $618.7M | ||
| Q3 25 | $372.2M | $938.9M | ||
| Q2 25 | $319.6M | $631.9M | ||
| Q1 25 | $475.8M | $1.1B | ||
| Q4 24 | $721.2M | $929.0M | ||
| Q3 24 | $406.6M | $950.1M | ||
| Q2 24 | $425.6M | $1.8B | ||
| Q1 24 | $394.4M | $843.0M |
| Q4 25 | $1.7B | $9.0B | ||
| Q3 25 | $1.7B | $8.9B | ||
| Q2 25 | $1.7B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.7B | $7.6B | ||
| Q3 24 | $1.9B | $7.6B | ||
| Q2 24 | $1.9B | $7.6B | ||
| Q1 24 | $2.1B | $6.1B |
| Q4 25 | $1.8B | $9.7B | ||
| Q3 25 | $1.7B | $9.6B | ||
| Q2 25 | $1.7B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $1.9B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.4B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
| Q4 25 | $5.1B | $19.6B | ||
| Q3 25 | $5.0B | $19.3B | ||
| Q2 25 | $5.0B | $18.3B | ||
| Q1 25 | $5.2B | $17.6B | ||
| Q4 24 | $5.2B | $18.2B | ||
| Q3 24 | $5.1B | $18.0B | ||
| Q2 24 | $4.9B | $17.7B | ||
| Q1 24 | $4.8B | $16.1B |
| Q4 25 | 0.95× | 0.92× | ||
| Q3 25 | 1.00× | 0.93× | ||
| Q2 25 | 0.98× | 0.84× | ||
| Q1 25 | 0.91× | 0.78× | ||
| Q4 24 | 0.93× | 0.74× | ||
| Q3 24 | 1.04× | 0.74× | ||
| Q2 24 | 1.37× | 0.78× | ||
| Q1 24 | 1.70× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $315.8M | $827.1M |
| Free Cash FlowOCF − Capex | $223.1M | — |
| FCF MarginFCF / Revenue | 19.0% | — |
| Capex IntensityCapex / Revenue | 7.9% | — |
| Cash ConversionOCF / Net Profit | 3.27× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $333.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $315.8M | $827.1M | ||
| Q3 25 | $229.5M | $702.6M | ||
| Q2 25 | $161.5M | $364.0M | ||
| Q1 25 | $-92.5M | $596.1M | ||
| Q4 24 | $380.9M | $742.5M | ||
| Q3 24 | $24.0M | $703.6M | ||
| Q2 24 | $101.1M | $658.2M | ||
| Q1 24 | $-98.8M | $664.6M |
| Q4 25 | $223.1M | — | ||
| Q3 25 | $167.0M | — | ||
| Q2 25 | $89.4M | — | ||
| Q1 25 | $-145.8M | — | ||
| Q4 24 | $333.6M | — | ||
| Q3 24 | $-41.8M | — | ||
| Q2 24 | $40.9M | — | ||
| Q1 24 | $-164.6M | — |
| Q4 25 | 19.0% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | -12.7% | — | ||
| Q4 24 | 28.4% | — | ||
| Q3 24 | -4.0% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -15.8% | — |
| Q4 25 | 7.9% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 6.3% | — |
| Q4 25 | 3.27× | 3.86× | ||
| Q3 25 | 2.09× | 2.44× | ||
| Q2 25 | 1.60× | 12.06× | ||
| Q1 25 | -0.95× | 2.50× | ||
| Q4 24 | 2.78× | 3.57× | ||
| Q3 24 | 0.29× | 1.29× | ||
| Q2 24 | 1.23× | 6.45× | ||
| Q1 24 | -1.49× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATI
| Other | $527.1M | 45% |
| Advanced Alloys Solutions | $333.5M | 28% |
| Airframes Commercial | $82.0M | 7% |
| Defense | $73.7M | 6% |
| Electronics Market | $53.1M | 5% |
| Internal Customers | $50.9M | 4% |
| Specialty Energy | $29.3M | 2% |
| Medical Market | $12.2M | 1% |
| Construction Mining Market | $7.2M | 1% |
| Other Market | $5.6M | 0% |
| Conventional Energy | $1.9M | 0% |
| Automotive Market | $600.0K | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
